Home › Basal Cell Carcinoma › NCT06473103
Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy
Recruiting
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * Undergoing treatment for basal cell carcinoma without Mohs surgery at the performance site * Able to read and understand consent form Exclusion Criteria: * None
About the study
The goal of this clinical trial is to compare the use of two photon fluorescence microscopy for detecting residual basal cell carcinoma during standard local excision.
What is being tested
- Two photon fluorescence microscopy imaging (device)
Sponsor: University of Rochester · Participants: 52 · Started: Oct 29, 2024
Contact the study team
- Michael Giacomelli, Ph.D. · Phone: 5852766260
Official record on ClinicalTrials.gov — NCT06473103
Locations in the U.S.
| New York | Rochester Dermatologic Surgery, Victor |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.